Back to results
US 2023/0116883 A1Published application
ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF
AssigneeThe Regents of the University of California
InventorsLee Woodland Riley, Nicole Jackson
Life of this patent
Estimating the term…
Abstract
The disclosure provides for a polyclonal antibody that specifically detects Acinetobacter baumannii, a multi-drug resistant (MDR) bacterial pathogen, and uses thereof, including as diagnostic tests and for immunoassays to be used in therapeutic decision-making or research experiments.
Claims23
A polyclonal antibody (pAb) which specifically binds to antigen(s) from Acinetobacter baumannii (A. baumannii), wherein the polyclonal antibody shows limited cross-reactivity to antigens from other gram-negative bacteria.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.